We are live on
!
Find out more
EIM
Essex Investment Management Portfolio holdings
AUM
$632M
1-Year Est. Return
95.36%
This Fund
S&P 500
This Quarter
Est. Return
-14.85%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$637M
AUM Growth
-$214M
(-25%)
Cap. Flow
-$70.8M
Cap. Flow
% of AUM
-11.11%
Top 10 Holdings %
Top 10 Hldgs %
18.21%
Holding
581
New
183
Increased
73
Reduced
207
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$14.4M |
| 2 |
Netflix
NFLX
|
+$9.91M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$8M |
| 4 |
Teladoc Health
TDOC
|
+$7.16M |
| 5 |
Ciena
CIEN
|
+$6.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.1M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$10M |
| 3 |
Biogen
BIIB
|
+$8.82M |
| 4 |
Alibaba
BABA
|
+$8.42M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 20.95% |
| 3 | Industrials | 11.87% |
| 4 | Financials | 8.28% |
| 5 | Consumer Discretionary | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBTM
351
JBT Marel
JBTM
$6.03B
| $156K | 0.02% |
2,174
-104
| -5% | -$9.22K |
|
352
Targa Resources
TRGP
$57.9B
| $152K | 0.02% |
4,212
-65
| -2% | -$3.15K |
|
353
Vista Gold
VGZ
$326M
| $147K | 0.02% |
+280,000
| New | +$144K |
|
354
Moderna
MRNA
$25.7B
| $146K | 0.02% |
+9,551
| New | +$157K |
|
355
Linde
LIN
$220B
| $144K | 0.02% |
+920
| New | +$145K |
|
356
Designer Brands
DBI
$312M
| $140K | 0.02% |
5,655
-272
| -5% | -$7.3K |
|
357
Pfizer
PFE
$153B
| $136K | 0.02% |
+3,288
| New | +$136K |
|
358
Bread Financial
BFH
$4.48B
| $135K | 0.02% |
1,129
-51
| -4% | -$8K |
|
359
Johnson & Johnson
JNJ
$630B
| $130K | 0.02% |
+1,007
| New | +$140K |
|
360
Blink Charging
BLNK
$86.2M
| $128K | 0.02% |
+74,372
| New | +$162K |
|
361
Abbott
ABT
$191B
| $125K | 0.02% |
+1,729
| New | +$122K |
|
362
VirTra
VTSI
$37.3M
| $121K | 0.02% |
+39,271
| New | +$168K |
|
363
Cincinnati Financial
CINF
$26.5B
| $119K | 0.02% |
+1,541
| New | +$120K |
|
364
Enterprise Products Partners
EPD
$82.1B
| $116K | 0.02% |
+4,710
| New | +$126K |
|
365
S&P Global
SPGI
$122B
| $108K | 0.02% |
+633
| New | +$113K |
|
|
X
366
DELISTED
US Steel
X
| $107K | 0.02% |
+5,881
| New | +$147K |
|
367
Southern Company
SO
$107B
| $105K | 0.02% |
+2,400
| New | +$109K |
|
|
VRML
368
DELISTED
Vermillion, Inc.
VRML
| $103K | 0.02% |
+342,082
| New | +$174K |
|
369
Nektar Therapeutics
NKTR
$2.59B
| $101K | 0.02% |
+204
| New | +$123K |
|
|
OTIV
370
DELISTED
OTI On Track Innovations Ltd
OTIV
| $100K | 0.02% |
170,164
-12,860
| -7% | -$10.5K |
|
|
EFOR
371
Everforth Inc
EFOR
$1.32B
| $98K | 0.02% |
+1,802
| New | +$117K |
|
372
AB InBev
BUD
$158B
| $96K | 0.02% |
+1,454
| New | +$111K |
|
373
Merck
MRK
$333B
| $95K | 0.01% |
+1,308
| New | +$92.3K |
|
374
Chubb
CB
$133B
| $94K | 0.01% |
+731
| New | +$94.5K |
|
375
Royal Gold
RGLD
$19.2B
| $94K | 0.01% |
+1,093
| New | +$84.1K |
|
Similar funds
BI
KCMH
SFM
VIM
AP
TTSTC
WCM
FTC
Essex Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, Essex Investment Management held 581 positions worth $637M, down 25% from $851M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Essex Investment Management withdrew a net $70.8M in Q4 2018, closing 105 positions and reducing 207 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $5.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Essex Investment Management opened a new position in NVIDIA worth $10.1M.
- Essex Investment Management's largest Q4 2018 buy was NVIDIA: 3,018,520 shares worth $10.1M.
- Essex Investment Management added most to VanEck Junior Gold Miners ETF in Q4 2018, an estimated $8M increase.
- Essex Investment Management's biggest Q4 2018 reduction was Apple, cutting an estimated $10.1M.
- Essex Investment Management fully exited Regeneron Pharmaceuticals in Q4 2018, selling an estimated $5.1M.
- Essex Investment Management's ten largest holdings make up 18% of its $637M portfolio in Q4 2018.
- Essex Investment Management opened 183 new positions and closed 105 in Q4 2018.
- Essex Investment Management's portfolio value fell 25% quarter-over-quarter to $637M.
Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.